| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 04/18/2007 | EP1773775A1 Six-membered heterocycles useful as serine protease inhibitors |
| 04/18/2007 | EP1773758A1 Oxime derivative hydroxyethylamine aspartyl-protease inhibitors |
| 04/18/2007 | EP1773756A2 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| 04/18/2007 | EP1773398A2 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease |
| 04/18/2007 | EP1773347A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 04/18/2007 | EP1773338A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 04/18/2007 | EP1773337A2 Modulators of nuclear receptors |
| 04/18/2007 | EP1553949B1 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 04/18/2007 | EP1476438B1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/18/2007 | EP1455792B1 Ureas of 2-aminobenzothiazoles as adenosine modulators |
| 04/18/2007 | EP1406893B1 Pyrrolidine bicyclic compounds |
| 04/18/2007 | EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 04/18/2007 | EP1028940B1 Process to produce oxazolidinones |
| 04/18/2007 | EP0964862B1 Insecticidal oxadiazine compounds |
| 04/18/2007 | CN1950393A Novel inhibitors of hepatitis c virus ns3 protease |
| 04/18/2007 | CN1950368A Pyrazolesulfonylurea compound and herbicide |
| 04/18/2007 | CN1950367A 2-styryl-4-oxazole-methanol-ethers and their use as tyrosine kinase inhibitors |
| 04/18/2007 | CN1950366A Thioether derivatives, their manufacture and use as pharmaceutical agents |
| 04/18/2007 | CN1950365A Indolyl derivatives as liver-X-receptor modulators |
| 04/18/2007 | CN1950351A 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands |
| 04/18/2007 | CN1950349A 1,2,4-oxadiazole derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| 04/18/2007 | CN1950348A Substituted morpholine compounds for the treatment of central nervous system disorders |
| 04/18/2007 | CN1950347A 2-aminoaryloxazole compounds as tyrosine kinase inhibitors |
| 04/18/2007 | CN1950089A Morpholine compounds |
| 04/18/2007 | CN1950085A 3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors |
| 04/18/2007 | CN1949966A Quinoxalin-2-one derivatives, crop protection agents comprising the same and method for production and use therof |
| 04/18/2007 | CN1948306A Fluoroquinolone-oxazolidone derivative, its preparation method and application |
| 04/18/2007 | CN1948305A New dioxo morpholine kind compound, its preparation method and use |
| 04/18/2007 | CN1310909C Novel heteroaryl derivatives, their prepn. and use |
| 04/18/2007 | CN1310907C Heterocyclic compound and antitumour agent containing the same as active ingredient |
| 04/18/2007 | CN1310897C A semi-synthetic process for the preparation of N debenzoylpaclitaxel |
| 04/17/2007 | USRE39575 For therapy of sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators |
| 04/17/2007 | US7205408 Therapy for bacteria infections in mammals |
| 04/17/2007 | US7205395 Process of preparing azithromycin and crystalline 9-deoxo-9a-aza-9a-homoerythromycin A hydrate used therein |
| 04/17/2007 | US7205394 Clathrate of azithromycin hydrate with 1,2-propyleneglycol, method for the manufacture thereof and pharmaceutical composition comprising same |
| 04/17/2007 | US7205330 can also modulate the processing of hepatitis C virus (HCV) polypeptide |
| 04/17/2007 | US7205326 Tyrosine inhibitor inhibitors; anticancer agents |
| 04/17/2007 | US7205325 Oxazole derivatives |
| 04/17/2007 | US7205324 IMPDH (inosine-5'-monophosphate dehydrogenase); transplant rejection and autoimmune diseases |
| 04/17/2007 | US7205319 N-[phenyl (piperidin-2-yl) methyl]benzamide derivatives, preparation thereof, and use thereof in therapy |
| 04/17/2007 | US7205318 Inhibitors of trypsin-like serine protease enzymes; for use as anticoagulant agents for therapy of thromboembolic disorders |
| 04/17/2007 | US7205312 As inhibitors of the retinoic acid-metabolism, as drugs; breast cancer; psoriasis |
| 04/17/2007 | US7205309 Obesity therapy; administering orlistat |
| 04/17/2007 | US7205307 Pyrimidines as novel openers of potassium ion channels |
| 04/17/2007 | US7205306 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 04/17/2007 | US7205304 medicine to inhibit proliferative conditions, such as cancer and psoriasis |
| 04/17/2007 | US7205300 Aryl fused azapolycyclic compounds |
| 04/17/2007 | US7205295 such as 4-(4-tert-Butyl-benzyl)-6-(4-oxo-2-thioxo-thiazolidin-5-ylidenemethyl)-4H-1,4-benzoxazin-3-one; phosphoinositide-3-kinases (PI3Ks); for treatment/prevention of inflammatory diseases, cardiovascular diseases, and cancers |
| 04/17/2007 | US7205292 Piperidines containing a lactam ring and a quinolinone, benzimidazolone, quinazolinone or benzodiazepinone group, e.g. N-[3R,7R)-1-(Cyclopropylmethyl)-2-oxo-7-phenylazepan-3-yl]-4-(2-oxo-1,4-dihydroquinazolin-3 (2H-yl)piperidine-1-carboxamide; treating headaches, migraine headaches and cluster headaches |
| 04/17/2007 | CA2371645C Naphtalene or heterocyclically substituted benzimidazoles as parp inhibitors |
| 04/17/2007 | CA2350073C Ccr5 modulators |
| 04/17/2007 | CA2299300C Arylpyridazinones as prostaglandin endoperoxide h synthase bisoynthesis inhibitors |
| 04/17/2007 | CA2203412C Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis |
| 04/12/2007 | WO2007041634A1 Pyrimidine amide compounds as pgds inhibitors |
| 04/12/2007 | WO2007040982A1 5- (phenylisoxazolylethoxy) -triazol- 3 -yl substituted pyridine compounds for the treatment of neurological, psychiatric or pain disorders |
| 04/12/2007 | WO2007040682A1 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation |
| 04/12/2007 | WO2007040681A1 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation |
| 04/12/2007 | WO2007040326A1 A novel oxazolidinone formamide derivative and preparation method therof |
| 04/12/2007 | WO2007040231A1 Quinazoline derivative and pharmaceutical |
| 04/12/2007 | WO2007040208A1 Nitrogen-containing heterocyclic compound and pharmaceutical application thereof |
| 04/12/2007 | WO2007039883A2 Process for preparation of aprepitant |
| 04/12/2007 | WO2007039782A1 Tetrazole derivatives as modulators of metabotropic glutamate receptors |
| 04/12/2007 | WO2007039781A2 1,2,4-oxadioi.e derivatives with activity at the metabotropic clutamate receptors |
| 04/12/2007 | WO2007039389A1 Isoxazolo derivatives as gaba a alpha5 inverse agonists |
| 04/12/2007 | WO2007039226A1 Diazine azole derivatives, their manufacture and use as pharmaceutical agents |
| 04/12/2007 | WO2007039176A1 Derivatives of 2 -aminthiazoles and 2-aminooxazoles, processes for their preparation and their use as pharmaceuticals |
| 04/12/2007 | WO2007039172A1 Phenyl- and pyridyl-i, 2 , 4 -oxadiazolone derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals |
| 04/12/2007 | WO2007039170A1 Antagonists of topoisomerase activity and their use in inhibiting pathological conditions |
| 04/12/2007 | WO2007039146A1 4-carboxy pyrazole derivatives as anti-viral agents |
| 04/12/2007 | WO2007039132A1 Novel polymorphous form and the amorphous form of 5-chloro-n-({ (5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide |
| 04/12/2007 | WO2007038865A1 Substituted quinolines as inhibitors of leukotriene biosynthesis |
| 04/12/2007 | WO2007002214A3 Acyl guanidines as beta-secretase inhibitors |
| 04/12/2007 | WO2006134163A3 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
| 04/12/2007 | WO2006114401A3 Novel cyclic amines |
| 04/12/2007 | WO2006104889A3 Novel compounds |
| 04/12/2007 | WO2006078598A3 Mitotic kinesin inhibitors |
| 04/12/2007 | US20070083046 Morpholine derivatives as norepinephrine reuptake inhibitors |
| 04/12/2007 | US20070083045 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase |
| 04/12/2007 | US20070082936 High affinity and selectivity for GABA A alpha 5 receptor binding sites; cognitive enhancer; Alzheimer's disease; 3-(5-methyl-3-phenyl-isoxazole-4-carbonyl)-1H-indole-6-carboxylic acid prop-2-ynylamide |
| 04/12/2007 | US20070082932 Pyrrolidine compounds |
| 04/12/2007 | US20070082931 7-Chloro-3-({5-[N-(morpholin-1-ylcarboxamido)methyl]aminomethyl}-([1,2,4]-thiadiazol-3-yl))-1-(tetrahydropyran-4-yl)methyl-1H-indole, hydrochloride salt; treatment of pain |
| 04/12/2007 | US20070082921 Quinazoline derivatives as antitumor agents |
| 04/12/2007 | US20070082912 Pyrrole compounds for the treatment of prostaglandine mediated diseases |
| 04/12/2007 | US20070082907 Peroxisome proliferator activated receptor modulators |
| 04/12/2007 | US20070082906 1-(1-{4-[3-(1,3-oxazol- 2-yl)-6-phenyl-1,2,4- triazin-5- yl]benzyl}piperidin-4- yl)-1,3-dihydro-2H- benzimidazol-2-one; inhibit activity of a serine, threonine protein kinase; hyperproliferative disorders, restenosis, inflammation, autoimmune diseases, allergy, asthma |
| 04/12/2007 | US20070082904 Cycloalkyl derivatives of 3-hydroxy-4-pyridinones field of the invention |
| 04/12/2007 | US20070082899 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 04/12/2007 | US20070082898 5 Amino-2-carbonylthiophene derivatives for use as p38 map kinase inhibitors in the treatment of inflammatory diseases |
| 04/12/2007 | US20070082897 Acylated indanyl amines and their use as pharmaceuticals |
| 04/12/2007 | US20070082896 4-{[3,5-Bis(trifluoromethyl)benzyl]-[5-(4-carboxybutoxy)pyrimidin-2-yl]}amino-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester; cholesteryl ester transfer protein (CETP) inhibitors; increasing HDL cholesterol; lowering LDL cholesterol; arteriosclerosis, hyperlipidemia |
| 04/12/2007 | US20070082895 Novel mycobacterial inhibitors |
| 04/12/2007 | US20070082894 Pyrazine-based tubulin inhibitors |
| 04/12/2007 | US20070082892 Benzotriazepine derivatives and their use as gastrin and cholecystokinin receptor ligands |
| 04/12/2007 | US20070082889 inhibitors of voltage-gated sodium channels; (R)-2-hydroxy-1-(4-(6-(2-hydroxyphenyl)pyridin-2-yl)piperazin-1-yl)-4-methylpentan-1-one; antiinflammation, arthritis, migraine, neuralgia, epilepsy, neurodegenerative and psychiatric disorders , anxiety and depression, myotonia, arrhythmia; cancer |
| 04/12/2007 | US20070082888 Containing a piperidine ring, e.g., N-(p-(1-(alpha(propyl-aminocarbonyl)benzyl)piperidin-4-yl)phen yl)-o-(p-CF3-phenyl)- benzamide, for therapy of hyperlipidemia, obesity and type II diabetes |
| 04/12/2007 | US20070082883 HIV protease inhibitors |
| 04/12/2007 | CA2823159A1 Polymorphic form of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide |
| 04/12/2007 | CA2624310A1 Polymorphic form of 5-chloro-n-({5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide |
| 04/12/2007 | CA2624294A1 Substituted quinolines as inhibitors of leukotriene biosynthesis |
| 04/12/2007 | CA2624141A1 Quinazoline derivative and pharmaceutical |